Biocellvia is an artificial intelligence company specializing in image analysis, with a strong expertise in digital pathology. Our technology, MorphoQuant™, provides objective quantification of pathological features for both preclinical and clinical studies using morphometric analysis. Developed by digital imaging specialists and biologists, our specific algorithms identify and quantify morphometric parameters, giving you a more evident go/no-go decision for your drug candidate.

Our fully automated and proven methodology ensures the most robust and reproducible data. Biocellvia's software is independent of human subjectivity and variability, making it a reliable tool. We use whole slide images with no prior selection of potential areas of interest, providing a comprehensive assessment.

To ensure reliability and comparison, we have standardized histology with specific stains and label combinations. Unreliable data can lead to the failure of drug candidates. However, our unique imaging technology banishes variability and brings absolute accuracy to your efficacy data.

With fast turnaround time, observer-independent results, and highly accurate data, Biocellvia enables researchers to make better decisions in drug discovery. Contact us at 10 rue Grignan, Marseille, France or call us at +33 4 91 06 18 26. Follow us on LinkedIn for regular updates and stay informed about our innovative applications